Methamphetamine decreases levels of glutathione peroxidases 1 and 4 in SH-SY5Y neuronal cells: Protective effects of selenium

NeuroToxicology

Volumn 37, Issue , 2013, Pages 240-246

  Barayuga, Stephanie M ^a,b   Pang, Xiaosha ^a,b   Andres, Marilou A ^a,b   Panee, Jun ^a,b   Bellinger, Frederick P ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Dopamine; Glutathione; Glutathione peroxidase; Methamphetamine; Oxidative stress; Selenium

Indexed keywords

GLUTATHIONE PEROXIDASE 1; METHAMPHETAMINE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; SELENIUM;

ARTICLE; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME METABOLISM; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CELL LINE, TUMOR; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; METHAMPHETAMINE; NEURONS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SODIUM SELENITE;

EID: 84879227816     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2013.05.009     Document Type: Article

References (42)

1. Acikgoz O., Gonenc S., Gezer S., Kayatekin B.M., Uysal N., Semin I., et al. Methamphetamine causes depletion of glutathione and an increase in oxidized glutathione in the rat striatum and prefrontal cortex. Neurotox Res 2001, 3:277-280.
2. Asensi M., Sastre J., Pallardo F.V., Lloret A., Lehner M., Garcia-de-la Asuncion J., et al. Ratio of reduced to oxidized glutathione as indicator of oxidative stress status and DNA damage. Methods Enzymol 1999, 299:267-276.
3. Bellinger F.P., Bellinger M.T., Seale L.A., Takemoto A.S., Raman A.V., Miki T., et al. Glutathione peroxidase 4 is associated with neuromelanin in substantia nigra and dystrophic axons in putamen of Parkinson's brain. Mol Neurodegener 2011, 6:8.
4. Berry M.J., Banu L., Harney J.W., Larsen P.R. Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. EMBO J 1993, 12:3315-3322.
5. Bolaños J.P., Almeida A., Stewart V., Peuchen S., Land J.M., Clark J.B., et al. Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem 1997, 68:2227-2240.
6. Brewer G.J., Torricelli J.R., Evege E.K., Price P.J. Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J Neurosci Res 1993, 35:567-576.
7. Brigelius-Flohé R. Glutathione peroxidases and redox-regulated transcription factors. Biol Chem 2006, 387:1329-1335.
8. Briviba K., Kissner R., Koppenol W.H., Sies H. Kinetic study of the reaction of glutathione peroxidase with peroxynitrite. Chem Res Toxicol 1998, 11:1398-1401.
9. Brown J.M., Quinton M.S., Yamamoto B.K. Methamphetamine-induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite. J Neurochem 2005, 95:429-436.
10. Castano A., Ayala A., Rodriguez-Gomez J.A., de la Cruz C.P., Revilla E., Cano J., et al. Increase in dopamine turnover and tyrosine hydroxylase enzyme in hippocampus of rats fed on low selenium diet. J Neurosci Res 1995, 42:684-691.
11. Castano A., Ayala A., Rodriguez-Gomez J.A., Herrera A.J., Cano J., Machado A. Low selenium diet increases the dopamine turnover in prefrontal cortex of the rat. Neurochem Int 1997, 30:549-555.
12. Dawson T.M., Dawson V.L., Snyder S.H. A novel neuronal messenger molecule in the brain: the free radical, nitric oxide. Ann Neurol 1992, 32:297-311.
13. Ernst T., Chang L., Leonido-Yee M., Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 2000, 54:1344-1349.
14. Hom D.G., Jiang D., Hong E.J., Mo J.Q., Andersen J.K. Elevated expression of glutathione peroxidase in PC12 cells results in protection against methamphetamine but not MPTP toxicity. Brain Res Mol Brain Res 1997, 46:154-160.
15. Homer B.D., Solomon T.M., Moeller R.W., Mascia A., DeRaleau L., Halkitis P.N. Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications. Psychol Bull 2008, 134:301-310.
16. Imam S.Z., Ali S.F. Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation. Brain Res 2000, 855:186-191.
17. Imam S.Z., el-Yazal J., Newport G.D., Itzhak Y., Cadet J.L., Slikker W., et al. Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann N Y Acad Sci 2001, 939:366-380.
18. Imam S.Z., Newport G.D., Islam F., Slikker W., Ali S.F. Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity. Brain Res 1999, 818:575-578.
19. Imam S.Z., Newport G.D., Islam F., Slikker W., Ali S.F. Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity. Brain Res 1999, 818:575-578.
20. Kim H.C., Jhoo W.K., Choi D.Y., Im D.H., Shin E.J., Suh J.H., et al. Protection of methamphetamine nigrostriatal toxicity by dietary selenium. Brain Res 1999, 851:76-86.
21. Kim H., Jhoo W., Shin E., Bing G. Selenium deficiency potentiates methamphetamine-induced nigral neuronal loss; comparison with MPTP model. Brain Res 2000, 862:247-252.
22. Krasnova I.N., Cadet J.L. Methamphetamine toxicity and messengers of death. Brain Res Rev 2009, 60:379-407.
23. LaVoie M.J., Hastings T.G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci 1999, 19:1484-1491.
24. Lei X.G., Evenson J.K., Thompson K.M., Sunde R.A. Glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase are differentially regulated in rats by dietary selenium. J Nutr 1995, 125:1438-1446.
25. Lopes F.M., Schroder R., da Frota M.L., Zanotto-Filho A., Muller C.B., Pires A.S., et al. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res 2010, 1337:85-94.
26. Mirecki A., Fitzmaurice P., Ang L., Kalasinsky K.S., Peretti F.J., Aiken S.S., et al. Brain antioxidant systems in human methamphetamine users. J Neurochem 2004, 89:1396-1408.
27. Moncada S., Bolaños J.P. Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 2006, 97:1676-1689.
28. Morio K.A., Marshall T.A., Qian F., Morgan T.A. Comparing diet, oral hygiene and caries status of adult methamphetamine users and nonusers: a pilot study. J Am Dent Assoc 2008, 139:171-176.
29. Nash J.F., Yamamoto B.K. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res 1992, 581:237-243.
30. Quinton M.S., Yamamoto B.K. Causes and consequences of methamphetamine and MDMA toxicity. AAPS J 2006, 8:E337-E347.
31. Romero-Ramos M., Venero J.L., Cano J., Machado A. Low selenium diet induces tyrosine hydroxylase enzyme in nigrostriatal system of the rat. Brain Res Mol Brain Res 2000, 84:7-16.
32. Roth S., Zhang S., Chiu J., Wirth E.K., Schweizer U. Development of a serum-free supplement for primary neuron culture reveals the interplay of selenium and vitamin E in neuronal survival. J Trace Elem Med Biol 2010, 24:130-137.
33. Seiden L.S., Sabol K.E., Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 1993, 33:639-677.
34. Seiler A., Schneider M., Forster H., Roth S., Wirth E.K., Culmsee C., et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab 2008, 8:237-248.
35. Sies H., Sharov V.S., Klotz L.O., Briviba K. Glutathione peroxidase protects against peroxynitrite-mediated oxidations: a new function for selenoproteins as peroxynitrite reductase. J Biol Chem 1997, 272:27812-27817.
36. Sulzer D., Pothos E., Sung H.M., Maidment N.T., Hoebel B.G., Rayport S. Weak base model of amphetamine action. Ann N Y Acad Sci 1992, 654:525-528.
37. Sulzer D., Rayport S. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 1990, 5:797-808.
38. Weiss Sachdev S., Sunde R.A. Selenium regulation of transcript abundance and translational efficiency of glutathione peroxidase-1 and -4 in rat liver. Biochem J 2001, 357:851-858.
39. Yamamoto B.K., Raudensky J. The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse. J Neuroimmune Pharmacol 2008, 3:203-217.
40. Yamamoto B.K., Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 1998, 287:107-114.
41. Yan J., Barrett J.N. Purification from bovine serum of a survival-promoting factor for cultured central neurons and its identification as selenoprotein-P. J Neurosci 1998, 18:8682-8691.
42. Zhang X., Tobwala S., Ercal N. N-acetylcysteine amide protects against methamphetamine-induced tissue damage in CD-1 mice. Hum Exp Toxicol 2012, 31:931-944.